Actuate Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Actuate Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $730.62K, a 84.19% decline year-over-year.
- Actuate Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $518.97K.
- Actuate Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was -$29.08K, a 100.13% decline year-over-year.
- Actuate Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $4.62M.
- Actuate Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2025 was $4.59M, a 79.15% decline from fiscal 2024.
- Actuate Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2024 was $22.03M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $730.62K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $518.97K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $4.59M 10-K · filed 2026-03-26 | |
| 2025-09-30 | -$29.08K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $4.62M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $22.03M 10-K · filed 2025-03-13 | |
| 2024-09-30 | $22.03M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |